Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK and PD of RO6864018 in Healthy Asian Subjects
NCT02015715Phase 1Completed
- Sponsor
- Roche
- Start
- Dec 2013
- Primary completion
- Nov 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing RO6864018 with Placebo (2 arms). Primary endpoint: Number of Participants With Adverse Events. Started Dec 2013; status: completed.
02
Drugs
RO6864018
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02015715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015715.